Amneal Pharmaceuticals, Inc. (AMRX)
14.82
+0.20
(+1.33%)
USD |
NASDAQ |
Feb 13, 16:00
14.82
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Total Liabilities (Quarterly) : 3.642B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Pfizer Inc. | -- |
| Apellis Pharmaceuticals, Inc. | 657.56M |
| Nektar Therapeutics | 216.26M |
| Innoviva, Inc. | 419.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Shareholders Equity (Quarterly) | -109.46M |
| Debt to Equity Ratio | -24.54 |
| Current Ratio | 2.132 |
| Net Debt Paydown Yield | 0.25% |